Skip to main content
. 2015 Jun 17;16:274. doi: 10.1186/s13063-015-0793-z

Table 2.

Visit schedule

Study time points (months)
0 0 ½ 3 6 9 12 15 18 21 24
Assessment Visit 1 Visit 2 Phone Call Visit 3 Visit 4 Phone Call Visit 5 Phone Call Visit 6 Phone Call Visit 7
Consent x
Enrolment/randomisation x
CT angiography x xa x
Ultrasound x x x x x
Blood test (safety) x x x x
Blood collection (study) x x x x x
Resting brachial BP x x x x x x
SF-36 questionnaire x x x
Physical assessments x± x x x x x
Medical examination x x x x
Resting ABI x x x
Collection of study medication x x x x
Return of study medication x x x x
Event outcomes x x x x x
AE and compliance check x x x x x x x x x

Physical assessments include: resting BP, resting heart rate, weight, hip and waist measurements, ±indicates an additional assessment of height. ABI, ankle brachial-index; AE, adverse effects; BP, blood pressure; CT, computed tomography

aThe Leiden and Stanford study centres will not perform 12-month CTAs due to local ethics regulations. The Stanford centre will utilize a slightly different study schedule. In place of the 2-week phone call and 3-month visit, participants will attend for a safety visit at 1 month for assessment of adherence to study treatment and medication side effects. Study medications will be prescribed at 3-month intervals with AE and compliance checks at 3, 9, 15 and 21 months